XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $808,000 | -1.1% | 79,539 | -38.6% | 0.22% | -35.4% |
| Q4 2018 | $817,000 | -52.2% | 129,539 | 0.0% | 0.34% | -46.1% |
| Q3 2018 | $1,710,000 | -25.3% | 129,539 | -47.9% | 0.63% | -21.6% |
| Q2 2018 | $2,289,000 | +36.7% | 248,823 | -27.2% | 0.81% | +25.4% |
| Q1 2018 | $1,675,000 | +73.0% | 341,884 | 0.0% | 0.64% | +113.6% |
| Q4 2017 | $968,000 | -12.7% | 341,884 | -9.0% | 0.30% | -3.5% |
| Q3 2017 | $1,109,000 | -6.3% | 375,784 | 0.0% | 0.31% | -21.6% |
| Q2 2017 | $1,184,000 | -22.3% | 375,784 | -1.3% | 0.40% | +38.1% |
| Q1 2017 | $1,523,000 | -50.6% | 380,784 | -5.0% | 0.29% | -57.1% |
| Q4 2016 | $3,085,000 | -7.7% | 400,677 | -2.9% | 0.67% | -22.8% |
| Q3 2016 | $3,341,000 | +29.7% | 412,479 | -5.5% | 0.87% | +60.3% |
| Q2 2016 | $2,575,000 | -15.6% | 436,384 | 0.0% | 0.54% | 0.0% |
| Q1 2016 | $3,050,000 | -13.1% | 436,384 | 0.0% | 0.54% | -18.4% |
| Q4 2015 | $3,509,000 | -4.5% | 436,384 | -1.9% | 0.67% | -12.4% |
| Q3 2015 | $3,673,000 | -28.4% | 444,655 | 0.0% | 0.76% | +17.4% |
| Q2 2015 | $5,127,000 | -32.8% | 444,655 | 0.0% | 0.65% | -31.6% |
| Q1 2015 | $7,626,000 | -13.2% | 444,655 | 0.0% | 0.95% | -6.5% |
| Q4 2014 | $8,782,000 | – | 444,655 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |